Paper28879693
Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: Review of a Minimally Invasive Treatment Option.
Gabrielson AT and 2 others. World J Mens Health, 2017. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: Review of a Minimally Invasive Treatment Option. Papers, record 28879693. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28879693
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: Review of a Minimally Invasive Treatment Option.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23376148 | Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. | J Urol | 2013 | https://conductscience.org/library/papers/23376148 | PubMed |
| 2 | 6291216 | Collagenase for Peyronie's disease experimental studies. | Urol Res | 1982 | https://conductscience.org/library/papers/6291216 | PubMed |
| 3 | 9523668 | Histological and ultrastructural alterations in an animal model of Peyronie's disease. | Br J Urol | 1998 | https://conductscience.org/library/papers/9523668 | PubMed |
| 4 | 1895413 | The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. | J Urol | 1991 | https://conductscience.org/library/papers/1895413 | PubMed |
| 5 | 10799245 | A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. | J Urol | 2000 | https://conductscience.org/library/papers/10799245 | PubMed |
| 6 | 17367443 | Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study. | J Sex Med | 2007 | https://conductscience.org/library/papers/17367443 | PubMed |
| 7 | 27544298 | Review of Management Options for Patients With Atypical Peyronie's Disease. | Sex Med Rev | 2017 | https://conductscience.org/library/papers/27544298 | PubMed |
| 8 | 9586617 | Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study. | Urology | 1998 | https://conductscience.org/library/papers/9586617 | PubMed |
| 9 | 16094040 | Peyronie's disease in diabetic patients being screened for erectile dysfunction. | J Urol | 2005 | https://conductscience.org/library/papers/16094040 | PubMed |
| 10 | 27211926 | Peyronie's Disease and Injectable Collagenase Clostridium histolyticum: Safety, Efficacy, and Improvements in Subjective Symptoms. | Urology | 2016 | https://conductscience.org/library/papers/27211926 | PubMed |
| 11 | 25388099 | Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study. | J Sex Med | 2015 | https://conductscience.org/library/papers/25388099 | PubMed |
| 12 | 27816605 | Impact of Number of Cycles of Collagenase Clostridium Histolyticum on Outcomes in Patients With Peyronie's Disease. | Urology | 2017 | https://conductscience.org/library/papers/27816605 | PubMed |
| 13 | 28612401 | Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol. | BJU Int | 2017 | https://conductscience.org/library/papers/28612401 | PubMed |
| 14 | 20666587 | Collagenase clostridium histolyticum for Dupuytren's contracture. | Expert Opin Biol Ther | 2010 | https://conductscience.org/library/papers/20666587 | PubMed |
| 15 | 20500447 | Peyronie's disease following radical prostatectomy: incidence and predictors. | J Sex Med | 2010 | https://conductscience.org/library/papers/20500447 | PubMed |
| 16 | 12686831 | Tunica albuginea tissue analysis after electromotive drug administration. | J Urol | 2003 | https://conductscience.org/library/papers/12686831 | PubMed |
| 17 | 15626876 | Peyronie's disease: advancements in recent surgical techniques. | Curr Opin Urol | 2004 | https://conductscience.org/library/papers/15626876 | PubMed |
| 18 | 15126819 | Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. | J Urol | 2004 | https://conductscience.org/library/papers/15126819 | PubMed |
| 19 | 4366338 | Toxicity of collagenase: the relation to enzyme therapy of disk herniation. | Clin Orthop Relat Res | 1974 | https://conductscience.org/library/papers/4366338 | PubMed |
| 20 | 2544990 | Microvascular response to locally injected collagenase. An experimental investigation in hamsters and rabbits. | Scand J Plast Reconstr Surg Hand Surg | 1989 | https://conductscience.org/library/papers/2544990 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40314553 | Outcomes and management of Peyronie's disease with combined treatment of collagenase clostridium histolyticum, vacuum erection device, and tadalafil. | Asian J Androl | 2025 | https://conductscience.org/library/papers/40314553 | PubMed |
| 36351188 | Multicenter Pivotal Study Demonstrates Safety and Efficacy of a New Cellulite Procedure: Final Results at 12 Months. | Aesthet Surg J | 2023 | https://conductscience.org/library/papers/36351188 | PubMed |
| 36211476 | Collagenase Clostridium histolyticum for the Treatment of Cellulite in the Buttocks and Thigh: Early Insights From Clinical Practice. | Aesthet Surg J Open Forum | 2022 | https://conductscience.org/library/papers/36211476 | PubMed |
| 34552787 | Peyronie's disease - outcomes of collagenase clostridium histolyticum injection: A systematic review. | Arab J Urol | 2021 | https://conductscience.org/library/papers/34552787 | PubMed |
| 33735499 | Evaluation of alternative diluents for clinical use of collagenase clostridium histolyticum (CCH-aaes). | J Cosmet Dermatol | 2021 | https://conductscience.org/library/papers/33735499 | PubMed |
| 31093703 | Management of Peyronie's disease with collagenase Clostridium histolyticum in the acute phase. | World J Urol | 2020 | https://conductscience.org/library/papers/31093703 | PubMed |
| 30929330 | Extracorporeal Shock Wave Therapy in Peyronie's Disease: Clinical Efficacy and Safety from a Single-Arm Observational Study. | World J Mens Health | 2019 | https://conductscience.org/library/papers/30929330 | PubMed |
| 30792820 | Non-invasive treatment in the management of Peyronie's disease. | Ther Adv Urol | 2019 | https://conductscience.org/library/papers/30792820 | PubMed |
| 29706035 | Silencing Histone Deacetylase 7 Alleviates Transforming Growth Factor-β1-Induced Profibrotic Responses in Fibroblasts Derived from Peyronie's Plaque. | World J Mens Health | 2018 | https://conductscience.org/library/papers/29706035 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| DES | 1674 | PubTator's text mining | https://conductscience.org/library/genes/1674 | NCBI Gene |
| ELN | 2006 | PubTator's text mining | https://conductscience.org/library/genes/2006 | NCBI Gene |
| FGB | 2244 | PubTator's text mining | https://conductscience.org/library/genes/2244 | NCBI Gene |
| FN1 | 2335 | PubTator's text mining | https://conductscience.org/library/genes/2335 | NCBI Gene |
| IFNA2 | 3440 | PubTator's text mining | https://conductscience.org/library/genes/3440 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
| TGFB2 | 7042 | PubTator's text mining | https://conductscience.org/library/genes/7042 | NCBI Gene |
| TGFB3 | 7043 | PubTator's text mining | https://conductscience.org/library/genes/7043 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28879693
GET https://conductscience.org/api/papers/v1/28879693/references?page=2